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Abstract
Background: Recent systematic reviews have suggested that pedometers may be effective
motivational tools to promote walking. However, studies tend to be of a relatively short duration,
with small clinical based samples. Further research is required to demonstrate their effectiveness
in adequately powered, community based studies.
Objective: Using a randomized controlled trial design, this study assessed the impact of a 12-week
graduated pedometer-based walking intervention on daily step-counts, self-reported physical
activity and health outcomes in a Scottish community sample not meeting current physical activity
recommendations.
Method: Sixty-three women and 16 men (49.2 years ± 8.8) were randomly assigned to either an
intervention (physical activity consultation and 12-week pedometer-based walking program) or
control (no action) group. Measures for step-counts, 7-day physical activity recall, affect, quality of
life (n = 79), body mass, BMI, % body fat, waist and hip circumference (n = 76), systolic/diastolic
blood pressure, total cholesterol and HDL cholesterol (n = 66) were taken at baseline and week
12. Analyses were performed on an intention to treat basis using 2-way mixed factorial analyses of
variance for parametric data and Mann Whitney and Wilcoxon tests for non-parametric data.
Results: Significant increases were found in the intervention group for step-counts (p < .001), time
spent in leisure walking (p = .02) and positive affect (p = .027). Significant decreases were found in
this group for time spent in weekday (p = .003), weekend (p = .001) and total sitting (p = .001) with
no corresponding changes in the control group. No significant changes in any other health
outcomes were found in either group. In comparison with the control group at week 12, the
intervention group reported a significantly greater number of minutes spent in leisure time (p =
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spent in weekend (p = .003) and total sitting (p = .022).
Conclusion: A pedometer-based walking program, incorporating a physical activity consultation,
is effective in promoting walking and improving positive affect over 12 weeks in community based
individuals. The discussion examines possible explanations for the lack of significant changes in
health outcomes. Continued follow-up of this study will examine adherence to the intervention and
possible resulting effects on health outcomes.
Background
Recent position statements have re-affirmed the benefits
of an active lifestyle [1,2]. The current physical activity rec-
ommendation for adults, aged between 18–65 years, to
promote and maintain health is to accumulate at least 30
minutes of moderately intense physical activity on at least
five days of the week. Promoting accumulative, lifestyle
physical activity is an ideal approach to combat the high
levels of inactivity evident in global populations [3,4].
Brisk walking has been suggested as the mode of physical
activity most likely to increase physical activity at a popu-
lation level [5] and is the most commonly reported mode
of physical activity amongst adults in many populations
[3,6]. It is available to almost all individuals with little risk
of injury, is a no cost activity and it can be incorporated
into peoples' daily routines [7]. Researchers have identi-
fied that self determined brisk walking, even in short
bouts of 10 minutes, for 30 minutes a day (including sim-
ple everyday walking activities such as walking a dog) pro-
duce moderate physical activity at the intensity required
to achieve health benefits [8,9].
Walking interventions can be effective in reducing body
weight, body mass index (BMI), waist and hip circumfer-
ence, body fat, blood pressure and the cholesterol:high-
density lipoprotein (HDL) ratio [10-16] and may be effec-
tive in improving mood, affect [14,17,18] and quality of
life [19]. Conversely, some studies have demonstrated
that a walking intervention is not sufficient to affect any of
these health-related outcomes [20-24]. The reasons for
such equivocal results are unclear, therefore determining
the potential health benefits that can be achieved through
walking is crucial to the public health message.
Whilst several meta-analytical and systematic reviews exist
that examine how best to promote physical activity
[25,26] there is comparatively limited evidence on the
most effective methods to specifically promote walking. A
recent systematic review from Ogilvie and colleagues
(2007) examined the effectiveness of interventions aimed
at increasing walking at both an individual and popula-
tion level. The review concluded that the strongest evi-
dence exists for tailored interventions that are targeted at
individuals most motivated to change. The authors sug-
gested that future studies should also attempt to examine
whether walking interventions "are sufficiently frequent,
intense, or sustained to produce measurable outcomes in
anthropometric, physiological, biochemical or clinical out-
comes" (Ogilvie et al., 2007 p.1207).
One category of intervention, discussed by Ogilvie and
colleagues, was the use of pedometers as an integral com-
ponent of the intervention. A substantial body of research
exists that supports the use of pedometers to measure
physical activity [27,28]. A recent systematic review exam-
ined the association between pedometer use, physical
activity levels and a variety of health related outcomes
[29]. The authors concluded that pedometer use was sig-
nificantly associated with increased physical activity levels
and reductions in BMI and systolic blood pressure. In
2006 the National Institute for Health and Clinical Excel-
lence (NICE) in the United Kingdom produced a review of
pedometer-based intervention studies between 1990 and
2005 [30]. Due to stringent inclusion criteria, conclusions
from this review were drawn from only four studies. Both
reviews provide support for the suggestion that pedome-
ters may be useful motivational tools for increasing walk-
ing. However, there are several limitations when
considering the volume of published studies in this area
highlighted by these reviews. Studies were predominantly
of short duration (< 12 weeks) and based in the United
States of America (USA) with small samples consisting
mostly of clinical sub-populations. There is limited evi-
dence regarding their effectiveness in non-clinical samples
or in countries other than the USA. Additionally, few stud-
ies reported more than one outcome variable of interest.
There is a need for cross-cultural, sufficiently powered ran-
domized controlled trials to further examine the effective-
ness of pedometers in a community setting.
Evidence from two of the studies included in the NICE
review suggests that a support structure, that addresses
social and cognitive factors, is required for a pedometer-
based intervention to be effective [22,31]. A physical
activity consultation, using a theoretically grounded
framework, constitutes one method of addressing these
factors that has been demonstrated to effectively promote
physical activity [26,32]. Researchers have suggested that
pedometers may provide an important point of discus-
sion for in-depth physical activity consultations [33] yetPage 2 of 15
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addressed by pedometer-based intervention studies.
The Walking for Well-being in the West (WWW) study is
a multi-dimensional community-based randomized con-
trolled trial which aims to promote and maintain
increased walking behavior through the use of physical
activity consultations and a pedometer-based walking
program. The purpose of this article is to investigate the
short term effects of a pedometer based intervention, in
conjunction with a physical activity consultation, on
walking behavior and health related outcomes in individ-
uals not meeting current physical activity guidelines. Full
details of the study design and rationale are reported else-
where [34] Details of the subsequent stages of the WWW
intervention study can be found on the Scottish Physical
Activity Research Collaboration website http://www.spar
coll.org.uk.
Methods
Recruitment
The WWW intervention was set in the surrounding com-
munity of a West of Scotland university. Recruitment was
targeted specifically at individuals in the lowest socio-eco-
nomic groups. Recruitment was targeted at data zones
within 1.5 km of the university campus that were ranked
within the top 15% of the Scottish Index of Multiple Dep-
rivation (SIMD) (i.e. the most deprived zones). The SIMD
is the official measure of relative area based deprivation in
Scotland and is based on 37 deprivation indicators across
7 domains: current income, employment, housing,
health, education, skills and training, and geographical
access to services and telecommunications. These meas-
ures are used to split the country into data zones of
between 500 and 1000 people, which are then ranked
from the most deprived (1) to least deprived (6505) on
the overall SIMD index. The sampling frame of 1.5 km
was utilised as it was estimated that this would provide a
sufficient number of participants who were within a suit-
able walking distance from the university campus for
assessments. Recruitment in the top 15% of the SIMD
index produced few responses and so recruitment was
extended to include all households within the specified
study area regardless of socio-economic status. Partici-
pants were recruited between August and December of
2006 using mail drops, adverts in a local newspaper, post-
ers (placed in physicians' surgeries and shops within the
study area) and community stalls.
Participants
Individuals interested in participating in the study con-
tacted the research team via email, telephone or postal
method and in turn were provided with further study
information through the individual's preferred mode of
contact. Upon satisfactory inspection of this information
individuals attended a screening meeting at the research
centre to determine suitability for participation. Inclusion
criteria were: independently ambulatory, English speak-
ing and between the ages of 18–65 years. Only individuals
who were self-classified as not meeting current physical
activity recommendations, by means of an adapted stage
of exercise behavior change model [35], were invited to
participate. This method of screening physical activity
behavior was chosen due to the uncertainty of how to
determine meeting current recommendations based on
the main outcome measure of pedometer step-counts.
Classification by stage of change has been shown to be
associated with several positive health habits such as
fewer health related costs and physical activity stage of
change was found to be behaviorally valid as evidenced by
self-reported physical activity, self-reported exercise, self-
reported sedentary behaviors, pedometers and physical
functioning [36]. Participants were also required to com-
plete the Physical Activity Readiness Questionnaire to
assess their suitability for an exercise program [37]. A pos-
itive response in this questionnaire required a letter of
approval from the participant's physician in order to take
part. Participants not meeting any aspect of these criteria
were excluded from participation and provided with writ-
ten information on the benefits of physical activity. Writ-
ten informed consent was obtained from all participants
for their involvement in the physical activity intervention.
Participants provided additional consent for the optional
health related outcome measures. Upon completion of
this initial screening meeting participants completed
baseline outcome measures and were subsequently rand-
omized. All research procedures were approved by the rel-
evant university research ethics committee. Data for this
stage of the study were collected between August 2006
and December 2006.
Randomization Procedure
The WWW study is a two group (intervention and control)
by six time points (baseline, 12, 24, 36, 48 and 60 week)
randomized controlled trial. The data reported in this
paper concerns the initial intervention stage from baseline
to 12 weeks. Randomization was carried out via an inde-
pendent interactive voice response system (IVRS) which
concealed all details of the randomization method from
the end users. The IVRS is an interactive telephone based
system which allows an authenticated caller (researchers)
to randomize a subject into the study. Randomization was
stratified by gender (male/female) and baseline step
counts (≤ 7,999/≥ 8000) creating a total of four distinct
stratification groups. Researchers who conducted the
physical activity consultations were not blinded to group
assignment in order to implement the physical activity
intervention. Additional researchers who performed phys-
iological measurements were blinded to group assign-
ment. The value of 8,000 steps was used as a stratificationPage 3 of 15
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step-count. This value has previously been used as a base-
line descriptor for sedentarism [38]. Researchers have also
suggested that individuals are more likely to attain public
health guidelines by walking at least 8000 steps/day [39].
Positive effects on conventional metabolic parameters,
such as blood pressure, have been found when steps are
above 8000 steps/day [40].
Outcome measures
Physical Activity
Daily physical activity was measured using two methods.
The primary outcome measure was steps/day measured by
the Omron HJ-109E Step-O-Meter (Omron Healthcare
UK Ltd). To the authors' knowledge this model of pedom-
eter has not been utilized in any previous intervention
studies. However, Ryan and colleagues have demon-
strated good inter-reliability between units and acceptable
accuracy (less than 5% error) at speeds above 1.56 m/s for
this model [41]. The Omron HJ-109E has several features
beneficial to an intervention of this nature, including a
cover to prevent accidental resetting and a 7-day memory
which negates the need for participants to record their
own step-counts. Daily physical activity was also meas-
ured using a 7-day recall of physical activity in the form of
the long (self-reported) version of the International Phys-
ical Activity Questionnaire (IPAQ) [42]. This subjective
measure of physical activity was used to examine changes
in modes of physical activity that would not be measured
by the pedometer such as swimming or other forms of
structured sport or exercise. The IPAQ long version is a 31-
item instrument that collects information about moderate
and vigorous physical activity across four domains: work-
related, transportation, housework/gardening, and leisure
time physical activity. This detail on specific physical
activity domains therefore allows researchers to identify
where changes in physical activity may have occurred.
Walking time is also included for the work, transport and
leisure domains. Two additional questions measure time
spent sitting which can be used as an indication of seden-
tary time.
Health Related Outcomes
Affect (an individuals feelings and emotions) was assessed
using the Positive and Negative Affect Schedule (PANAS)
[43] which has been demonstrated to be a valid and relia-
ble measure of the constructs in a non-clinical sample of
U.K. adults [44]. The PANAS is a self report measure con-
sisting of 10 words relating to positive feelings and emo-
tions, such as 'interested' and 'alert', and 10 words that
relate to negative feelings such as 'distressed' and 'upset'.
Participants are asked to rate each item according to what
extent they have felt that way in the previous few weeks
using a Likert scale from (1) very slightly or not at all to
(5) extremely. Items were summed to give mean scores
(out of 50) for positive affect and negative affect.
Quality of life was measured using the Euroqol EQ-5D
instrument [45]. The EQ-5D is a self-report questionnaire
comprised of the EQ-5D descriptive system and the EQ
VAS. The EQ-5D descriptive system is a five item question-
naire that assesses participants' current health state over
five dimensions: mobility; self-care; usual activities; pain/
discomfort; and anxiety/depression. Each item is com-
prised of three levels (no problems, some/moderate prob-
lems, extreme problems). A unique health state can be
obtained by combining the participants' levels from the
five dimensions. The score can then be converted into a
weighted health index using "value sets" gained from pop-
ulation data. The UK value set, developed by Dolan and
colleagues, was used in this study [46]. The EQ VAS
records an individual's self-rated health status on a verti-
cal graduated (0 to 100) visual analogue scale.
Body mass was measured on a precision balance (Sarto-
rius, AG Gottingen, accuracy ± 0.001 kg). From these
measurements body mass index (BMI) was calculated as
height(m)/weight(kg)2; height was measured using a
standard laboratory stadometer. Waist-to-hip ratio was
calculated from measurements made using a SECA 200
(SECA, Birmingham, UK) measuring tape. Percentage
body fat was estimated from skinfold thickness
(Harpenden, British Indicators, West Sussex, UK) meas-
urements taken at four sites (biceps, triceps, subscapularis
and suprailiac) according to the methods of Durnin and
Womersley [47].
Blood pressure was measured using an automated blood
pressure monitor (Omron HEM-907, Bannockburn, IL).
On each visit blood pressure measurements were per-
formed three times with a rest period of one minute
between measurements. Three measurements of resting
heart rate were also recorded simultaneously by the blood
pressure monitor. The average of these measurements is
reported in these results.
Fasting blood samples were taken from an intravenous
butterfly cannula inserted into an antecubital vein. Sam-
ples were drawn into K+EDTA vacutainers (BD Bio-
sciences, Oxford, UK) which were centrifuged and the
plasma removed and stored at -80°C for subsequent anal-
ysis. Total cholesterol and high-density lipoprotein
(HDL) cholesterol (direct method), from the plasma,
were measured in duplicate on a fully automated spectro-
photometric analyzer (Pentra 400, Horiba-ABX, Montpel-
lier, France) using commercially available kits (Horiba-
ABX, Montpellier, France). The co-efficient of variation for
these assays was as follows: total cholesterol: 1.4%, HDL-
cholesterol: 1.6%.Page 4 of 15
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All participants completed a baseline week wearing a ped-
ometer, sealed with tape, for seven days at all times
(except when showering, sleeping or taking part in struc-
tured sport or exercise) with instructions not to alter their
daily routine. The WWW study was designed to impact
walking behavior therefore only ambulatory activity was
recorded. Irregular bouts of structured sport or exercise
that could significantly affect an individual's mean step-
count were not recorded. Each pedometer was individu-
ally calibrated consistent with manufacturers guidelines
to within 5% of actual steps walked in a 100-step test. Par-
ticipants were required to provide at least five days of step
counts including at least one weekend day to gain an accu-
rate reflection of physical activity levels. Pre-intervention
measures of all health related outcomes were obtained
and participants completed the IPAQ before being ran-
domly assigned to either intervention or control group.
Participants assigned to the intervention group received a
physical activity consultation and then followed a 12-
week pedometer-based walking program. The sessions
were based on a theoretical framework, recommended to
ensure quality [48]. The Transtheoretical Model of exer-
cise behavior change (TTM) [49] was chosen for this pur-
pose as there are published guidelines for health
professionals to conduct consultations using this model
as a theoretical framework [50,51]. The TTM is a common
theoretical framework for physical activity consultations
[52] and has been used successfully in intervention stud-
ies designed to increase physical activity in a Scottish pop-
ulation [32,53,54].
The consultations were semi-structured following estab-
lished guidelines [50,51]. A guiding style was used with
participants making decisions about how to change their
walking behavior [55]. The consultations were focused on
the uptake of physical activity, in this context promoting
increases in walking. Strategies used included enhancing
motivation, overcoming barriers and developing appro-
priate walking plans which were tailored to the individual
as recommended by Ogilvie and colleagues (2007). The
sessions also included discussion of the three mediators of
the TTM that have been shown to be important to behav-
ior change [49]. These are self-efficacy (confidence in abil-
ity to change), decisional balance (pros and cons of
change) and processes of change (strategies and tech-
niques used to change, e.g., social support). Although the
sessions were flexible and individualized, the TTM was
used to create a standard protocol to follow during the ses-
sions. Table 1 shows the steps followed.
The walking program was based on a 12-week time frame:
the first six weeks consisted of graduated bi-monthly goals
with an aim for the increased walking behavior to be
maintained for the remaining six weeks. The overall goal
of the walking program was for participants to increase
their mean daily step-count by 3,000 accumulated steps
above their baseline value on five days of the week. This
value is based on the assumption that moderate brisk
walking produces 100 steps a minute (1,000 steps per 10
minutes) [56] therefore 3,000 steps would equate to
approximately 30 minutes of moderate physical activity,
in line with current physical activity recommendations
[57]. This program has previously been successfully used
with similar UK samples over a shorter time-frame [58].
Intervention group participants retained their pedome-
ters, open for feedback, for the duration of the interven-
tion period and were shown how to use this to monitor
their daily step-counts. The full list of goals is displayed in
Table 2. Goals were retained for two consecutive weeks to
enable participants to reinforce their increased levels of
walking, or to try other strategies to successfully accumu-
late the additional steps. Participants were advised on the
nature of the intensity and duration of the desired
increases in walking. Participants were familiarized with
the Borg 6–20 scale [59] and advised that additional walk-
ing should be of a brisk nature that would leave them
slightly breathless and hot but still able to talk (indicated
as between 12–14 on this scale). Bouts of at least 10 min-
utes in duration were advised for additional walking
although the accumulation of walking during everyday
tasks wherever possible was also advocated.
Participants assigned to the control group were asked to
maintain their normal walking levels between baseline
Table 1: Key points covered during physical activity consultations
Key points covered
Step 1: Physical Activity 
History
• Participants' reasons for increasing 
walking
• Consider why walking is attractive to 
them
• Current walking levels
Step 2: Decisional Balance • Weigh up pros and cons of increasing 
walking
• Minimize any perceived cons
Step 3: Barriers • Consider barriers to increasing walking
• Consider how to overcome these 
barriers
Step 4: Goal-setting • Explanation of walking program and 
pedometer
• Informed of baseline step-counts
• Discuss realistic and time-phased goals
• Identify situations for increasing walking
• Identify local walking routes
Step 5: Summarize • Check self-efficacy of achieving goalsPage 5 of 15
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lected an individually calibrated pedometer from the
research centre and wore this sealed during week 12 to
gain a record of their step-counts. At the end of week 12
researchers met with all participants to record step-counts
at which time participants completed the IPAQ and post-
intervention health measures were taken.
Statistical Power and Analyses
G-Power analysis [60] set for F-test analysis of variance
(ANOVA) was used to calculate sample size for between
group analyses of the primary outcome measure (i.e.,
daily step count). Power was set at 0.8, Alpha level was set
at 0.05 and effect size (Cohen's f [61]) was set at 0.4
(large) for the two group (intervention and control)
design based on previous unpublished work from this
research group. A minimum sample size of 52 was calcu-
lated (26 participants in each group).
Data were analyzed using SPSS v.14.0 (SPSS, Inc, Chicago,
IL). All results reported were analyzed by the main inter-
vention groups: analyses by separate stratification varia-
bles (gender, baseline step-count) found no significant
interaction effects between groups (males/females and ≤
7,999/≥ 8000) therefore are not presented here. The anal-
yses were performed on an intention to treat basis. Miss-
ing week 12 data (due to participant drop-out) were
substituted with the participants' baseline value. Baseline
differences between the intervention and control group
were examined using independent t-tests. Steps/day and
health related outcome data were analyzed using two-way
mixed factorial analyses of variance (ANOVA). Missing
weekday step-count data were replaced by inputting the
mean of the remaining weekdays and missing weekend
step-count data were replaced by inputting the alternate
weekend day [62]. Exploratory analysis revealed that data
from several sub-sections of the IPAQ were non-normally
distributed. Non-parametric analyses were therefore used
to analyze these data. Mann Whitney U tests were used to
examine between group differences and Wilcoxon's
signed-rank tests were used to examine within group dif-
ferences over time. Due to the number of variables availa-
ble from the IPAQ only statistically significant results are
presented. Statistical significance was defined as p < 0.05
for all tests with data presented as mean (SD) unless oth-
erwise stated.
Results
Participants
From 169 initial enquiries to the study, 91 individuals
met the inclusion criteria and provided informed consent
at an initial meeting. Seventy-nine participants (63
females, 16 males, age = 49.2 ± 8.9) provided baseline
measurements of pedometer step counts, IPAQ and meas-
ures of affect and quality of life (specific numbers for par-
ticipants who consented to other health related outcome
measures can be found in Table 4). The intervention
group (n = 39) consisted of 31 females and eight males
and the control group (n = 40) consisted of 32 females
and eight males. Overall, 55 of 79 participants (70%)
were below the randomization stratification variable of
8,000 steps at baseline: this consisted of 28 of 39 (72%)
of participants in the intervention group and 27 of 40
(68%) of participants in the control group. Figure 1 dis-
plays the flow of participants through the study. As shown
in Figure 1 there were 15 participants who withdrew from
the study between baseline and week 12. The following
results are presented on an intention to treat basis where
all participants were considered. Table 3 displays the pro-
portion of participants in each level of the five dimensions
in the EQ-5D descriptive system. Table 4 displays descrip-
tive statistics (mean [M] and standard deviation [SD]) for
age, pedometer steps and all health related outcomes, at
baseline and week 12. Table 5 displays descriptive statis-
tics (median [Mdn] and range [r] for all IPAQ variables at
baseline and week 12.
Physical Activity
Step counts
Figure 2 displays the mean steps/day for both groups at
both time-points. A significant interaction was identified
between group (intervention, control) and time (baseline,
week 12) in terms of the recorded step-counts, (F(1,77) =
25.18, p < .001, partial η2 0.25). A paired t-test found a sig-
Table 2: Weekly goals of intervention group participants
Time-point Goal
Week 1 To walk an extra 1,500 steps (from baseline value) on at least 3 days of the week
Week 2 To walk an extra 1,500 steps (from baseline value) on at least 3 days of the week
Week 3 To walk an extra 1,500 steps (from baseline value) on at least 5 days of the week
Week 4 To walk an extra 1,500 steps (from baseline value) on at least 5 days of the week
Week 5 To walk an extra 3,000 steps (from baseline value) on at least 3 days of the week
Week 6 To walk an extra 3,000 steps (from baseline value) on at least 3 days of the week
Week 7 To walk an extra 3,000 steps (from baseline value) on at least 5 days of the week
Week 8 To walk an extra 3,000 steps (from baseline value) on at least 5 days of the week
Weeks 9–12 To maintain walking levels using the week 7 goalPage 6 of 15
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Flow of participants through the studyigure 1
Flow of participants through the study.
Initial Enquiries (n=169)
Excluded (n=12) 
  Became pregnant (n=1 
  Family bereavement (n=1) 
  No longer interested (n=1) 
  Not contactable (n=2) 
  Non attendance (n =2) 
  Did not meet inclusion criteria (n=5)
Pre-screening meeting (n=91)
Excluded (n=11) 
  Non-attendance (n=5) 
  Did not meet inclusion criteria (n=2)
  Injury (n=2) 
  Not contactable (n=1) 
  Did not return GP’s letter (n =1)
Randomized (n=80)
Assigned to intervention (n=39)
Withdrew dur ing meeting (n=1) 
  Randomised to control group (n=1) 
Provided week 12 measures (n=32) Provided week 12 measures (n=32) 
Lost to follow-up (n=8) 
  Injury (n=3) 
  Randomised to control (n=1)
  Other commitments (n=1) 
  Personal reasons (n=1) 
  Non-contactable (n =1) 
  Dissatisfaction with    
  pedometer (n=1)
Assigned to control (n=40) 
Lost to follow-up (n=7) 
  Personal reasons (n=3) 
  Injury (n=2) 
  Failed to turn up (n=1) 
  Not contactable (n=1) 
Returned study information (n=103)
International Journal of Behavioral Nutrition and Physical Activity 2008, 5:44 http://www.ijbnpa.org/content/5/1/44nificant increase in steps/day for the intervention group
between baseline (M = 6802, SD = 3212) and week 12 (M
= 9977, SD = 4669, t(38) = -6.06, p < .001, d = 0.79, con-
fidence intervals [CI] 2,115 – 4236). No significant differ-
ence was observed in the control group between baseline
(M = 6924, SD = 3201) and week 12 (M = 7078, SD 2911,
t(39) = -0.50, p = 0.618, CI -463 – 770). The mean differ-
ence in change between the two groups was 3,022 steps/
day and was statistically significant (t(77) = 5.02, p < .001,
d = 1.96). Chi-square analysis determined that a signifi-
cantly greater percentage (χ2 = 24.88, p < .001) of partici-
pants in the intervention group (25/39, 64%) achieved an
increase of 15,000 steps per week, equivalent to physical
activity guidelines of the accumulation of 150 minutes of
moderate physical activity, compared with the control
group (4/40, 10%).
7-day recall of physical activity (IPAQ)
Wilcoxon's signed-rank tests revealed that at week 12 the
intervention group recalled a significant increase in the
number of leisure minutes walked (Z = 2.32, p = 0.02, r =
0.37, median [Mdn] difference = 100 minutes per week)
and a significant decrease in weekday sitting (Z = 2.94, p
= 0.003, r = 0.47, Mdn difference = 1200 minutes per
week), weekend sitting (Z = 3.41, p = 0.001, r = 0.55, Mdn
difference 360 minutes per week) and total sitting (Z =
3.38, p = 0.001, r = 0.54, Mdn difference = 1680 minutes
per week) from baseline. At week 12 the control group
Table 4: Descriptive statistics for age, pedometer step-counts and health related outcomes at baseline and week 12 for intervention 
and control group. Values are mean (M) and standard deviation (SD).
Intervention Group (n = 39) Control Group (n = 40)
Baseline Week 12 Baseline Week 12
Age (years) 47.3 (9.3) a 51.2 (7.9) a
Steps/day 6802 (3212) 9977 (4669) 6924 (3201) 7078 (2911)
PANAS positive 31.2 (6.7) 33.5 (7.4) 31.7 (6.9) 31.3 (7.6)
PANAS negative 20.1 (7.2) 19.1 (6.9) 20.2 (8.1) 18.8 (7.5)
EQ-5D tariff 0.88 (0.12) 0.89 (0.11) 0.87 (0.12) 0.89 (0.12)
EQ VAS 65.4 (18.3) 69.5 (17.8) 69.8 (19.7) 70.7 (18.6)
Height (m)b 1.66 (0.08) a 1.64 (0.08) a
Body Mass (kg)b 78.9 (15.6) 79.1 (15.2) 79.5 (18.1) 79.6 (17.8)
BMI (kg/m2)b 28.5 (4.8) 28.7 (4.8) 29.4 (6.3) 29.5 (6.2)
Waist circumference (cm)b 89.5 (12.6) 89.9 (12.6) 90.4 (14.6) 91.1 (15.6)
Hip circumference (cm)b 108.9 (8.8) 108.6 (9.7) 110.1 (12.4) 110.3 (11.8)
Waist:Hip Ratiob 0.82 (0.08) 0.83 (0.08) 0.82 (0.09) 0.82 (0.09)
% body fatb 30.7 (4.4) 31. (4.9) 31.8 (5.6) 32.7 (6.3)
Systolic blood pressure (mm Hg)b 118.2 (17.9) 119.6 (17.0) 119.9 (15.9) 121.9 (15.1)
Diastolic blood pressure (mm Hg)b 75.1 (11.4) 77.1 (12.1) 75.5 (11.8) 79.1 (11.6)
Heart Rate (beats.min-1)c 68.6 (7.2) 69.8 (7.2) 67.9 (8.6) 69.2 (9.0)
Total Cholesterol (mmol.l-1)c 5.4 (1.3) 5.4 (1.2) 5.5 (1.1) 5.5 (1.0)
HDL (mmol-1)c 1.3 (0.3) 50.7 1.3 (0.3) 1.4 (0.4) 54.6 1.4 (0.4)
Chol:HDL Ratioc 4.2 (1.1) 4.2 (1.1) 4.1 (1.2) 4.0 (1.3)
a not measured at week 12.
b anthropometric measures: (n = 37) for intervention group, (n = 39) for control group.
c blood measures: (n = 32) for intervention group, (n = 34) for control group.
Note: there were no significant differences between the intervention and control group for any variable at baseline.
Table 3: Number of participants in each level for the five domains of the EuroQol EQ-5D descriptive system
Mobility Self Care Usual Care Pain/Discomfort Anxiety/Depression
Baseline Week 12 Baseline Week 12 Baseline Week 12 Baseline Week 12 Baseline Week 12
No Problems Interventiona 34 33 39 39 35 34 27 30 25 24
Controlb 33 33 40 40 35 35 26 28 28 27
Some/Moderate Intervention 5 6 0 0 4 5 12 9 14 15
Control 7 7 0 0 5 5 14 12 12 13
Extreme Problems Intervention 0 0 0 0 0 0 0 0 0 0
Control 0 0 0 0 0 0 0 0 0 0
a intervention group (n = 39).
b control group (n = 40)Page 8 of 15
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minutes of physical activity (Z = 2.02, p = 0.043, r = 0.32,
Mdn difference = 0 minutes) than at baseline. This result
is due to five individuals in the control group increasing
their vigorous leisure minutes recalled. As the majority of
participants (34 of 40) report zero minutes at both time-
points the median difference equals zero despite the
group reporting a significant increase.
Mann Whitney U tests revealed that at week 12 the inter-
vention group recalled a significantly greater number of
leisure minutes walked (U = 513.00, p = 0.008, r = 0.30,
Mdn difference 83.8 minutes), number of occupational
minutes walked (U = 602.00, p = 0.045, r = 0.23, Mdn dif-
ference 0 minutes) and total number of minutes walked
(U = 560.50, p = 0.03, r = 0.24, Mdn difference = 57.5 min-
utes) than the control group. The intervention group also
recalled significantly less total time spent sitting (U =
546.00, p = 0.022, r = 0.26, Mdn difference = -420 min-
utes) due to significantly less time spent sitting at the
weekend (U = 474.50, p = 0.003, r = 0.34, Mdn difference
= -240 minutes).
Health related outcomes
Affect (PANAS)
A significant interaction was identified between group
(intervention, control) and time (baseline, week 12) in
terms of the positive affect scores, (F(1,77) = 4.26, p = .042,
partial η2 0.05). A paired t-test found a significant increase
in positive affect for the intervention group between base-
line (M = 31.2, SD = 6.7) and week 12 (M = 33.5, SD = 7.4,
t(38) = 2.29, p = .027, d = 0.33, CI .27 – 4.39). No signif-
icant difference was observed in the control group
between baseline (M = 31.7, SD = 6.9) and week 12 (M =
31.3, SD 7.6, t(39) = -0.524, p = 0.604, -2.31 – 1.36).
There was no significant interaction or main effect found
for the negative affect scores or for any of the other health
related outcomes measured in the present study (Table 4).
Table 5: Descriptive statistics for IPAQ variables at baseline and week 12. Values are median (Mdn) and range (r).
Intervention Group (n = 39) Control Group (n = 40)
Baseline Week 12 Baseline Week 12
Work-related PA
Vigorous PA 0 (1080) 0 (1800) 0 (720) 0 (540)
Moderate PA 0 (1500) 0 (900) 0 (1500) 0 (600)
Walking 0 (1620) 0 (2520) 0 (1350) 0 (1650)
Total 0 (3000) 0 (4680) 0 (2500) 0 (2730)
Transportation PA
Bicycling 0 (0) 0 (0) 0 (40) 0 (0)
Walking 105 (1680) 90 (900) 80 (1680) 40 (840)
Total 105 (1680) 90 (900) 80 (1720) 40 (840)
Housework PA
Vigorous outside home 0 (840) 0 (120) 0 (750) 0 (360)
Moderate outside home 0 (2100) 0 (1680) 0 (1260) 0 (720)
Moderate inside home 210 (2100) 112.5 (840) 180 (1680) 90 (1260)
Total 360 (4200) 120 (2520) 255 (2640) 145 (2100)
Leisure-time PA
Walking 40 (840) 100 (840) 35 (600) 16.25 (840)
Vigorous PA 0 (180) 0 (120) 0 (180) 0 (180)
Moderate PA 0 (360) 0 (60) 0 (120) 0 (600)
Total 60 (840) 90 (840) 60 (600) 11 (840)
Combined Domains
Total Walking 225 (3360) 260 (2850) 167.5 (1740) 90 (1925)
Total Moderate PA 420 (4380) 120 (2760) 360 (2640) 175 (2100)
Total Vigorous PA 0 (1080) 0 (1800) 0 (720) 0 (600)
Total PA 690 (6300) 590 (5415) 640 (4300) 500 (3185)
Time Spent Sitting
Weekday 1500 (3750) 1200 (3900) 1500 (3450) 1500 (2850)
Weekend 480 (1320) 360 (1200) 600 (1200) 600 (1320)
Total 2265 (4650) 1680 (5100) 2130 (4170) 2100 (3630)Page 9 of 15
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This study is one of the first adequately powered, UK
based randomized controlled trials to examine the impact
of a pedometer-based walking intervention on step-
counts in a community setting. The major finding of this
study was that a graduated pedometer-based walking pro-
gram, in conjunction with a physical activity consultation
increased walking in low-active adults over a period of 12
weeks. The control group, included to account for the
intrinsic motivation of volunteer participants [63], dis-
played no significant change in steps/day over time. The
conservative intention to treat analysis (baseline carried
forward for missing values) produced a mean change in
the intervention group of 3,175 steps/day, an increase of
47% above baseline values, a favorable increase compared
with other pedometer-based randomized controlled trials
[22,31,33]. In their systematic review, Bravata and col-
leagues (2007) reported that pedometer users increase
physical activity by an average of 26.9% over baseline val-
ues.
The overall goal for participants was to increase their base-
line step-counts by 3,000 steps/day on five days of the
week (i.e., equivalent to current physical activity recom-
mendations); equating to an overall weekly increase of
15,000 steps/week. The intervention group displayed a
mean increase in weekly step counts of 22,225 steps/week
thus exceeding the recommended goal. At an individual
level 64% of participants in the intervention group
achieved the goal of 15,000 steps/week. Participants in
the intervention group progressed from being classified as
"low active" (5,000–7,499 steps/day) to within 23 steps of
being classed as "active" (≥ 10,000) according to sug-
gested public health ranges for pedometer counts [64].
These results suggest that the intervention is a successful
method of promoting walking and allowing individuals
to meet suggested public health recommendations.
One issue of the study, also discussed in the Bravata et al.
systematic review, is that it is not possible to disentangle
the respective contributions of the physical activity con-
sultation from the benefits of the pedometer-based goals
of the walking program. Physical activity consultations
have been demonstrated to be effective at promoting
physical activity [32,54], and this particular walking pro-
gram has previously been shown to be effective at promot-
ing short-term increases in walking [58]. Consistent with
recommendations from Bravata and colleagues, the next
stage of the WWW project involves the control group fol-
lowing the 12 week walking program without the addi-
tional physical activity consultation, while the
intervention group will be provided with continued sup-
port in the form of a further physical activity consultation.
These longer term comparative results will help to deter-
mine the most effective components of this intervention.
The increase observed in the step-count data was sup-
ported by the self-reported results of the IPAQ; an increase
in reported minutes of leisure time walking was found in
the intervention group (median increase of 100 minutes
per/week). While it is not directly comparable, the
increase of 22,225 steps/week observed in the interven-
tion group is approximately equivalent to an additional
222 minutes of walking per week. Although we must con-
sider possible errors in perception when recalling walking
[65] this suggests that the primary means by which partic-
ipants increased their walking was during their leisure
time, consistent with previous research [66]. The discrep-
ancy between the objective and subjective measures of
activity could be partially explained by the pedometer
measuring all activity and the IPAQ only measuring activ-
ity in bouts of 10 minutes and greater. Alternatively, addi-
tional increases in step-counts could be attributed to an
accumulation of walking in other domains and other
non-significant increases in ambulatory activity. This may
be demonstrated in the significant difference in occupa-
tional and total minutes of walking recalled between the
intervention and control groups at week 12.
The IPAQ also revealed that the intervention group
reduced time spent sitting during both weekdays and
weekend days. Researchers have suggested that sedentary
behavior, such as time spent sitting, is positively associ-
ated with coronary heart disease risk factors, obesity and
Mean steps/day for intervention group (n = 39) and control group (n = 40) at baseline and week 12Fig re 2
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been suggested that interventions should seek to both
increase physical activity and to decrease sedentary behav-
ior [70]. In this study we did not aim to directly reduce
sedentary behavior and as the IPAQ does not measure sit-
ting time across a specific domain it is impossible to deter-
mine where the reductions in sitting time occurred. Future
interventions incorporating physical activity consulta-
tions should ensure that identifying and reducing seden-
tary behaviors is an integral part of the consultation
process and that any physical activity questionnaires used
should describe sedentary behaviors to the same extent as
physical activity behaviors. These results should be treated
with a degree of caution given the disparity between the
reduced time spent sitting as indicated by the IPAQ (4
hours of total sitting per day) and the increase in physical
activity as measured by the pedometer (approximately 30
minutes of activity per day). It may be possible that non-
sitting activities such as standing may attribute to a pro-
portion of this difference however this does not provide
an adequate explanation given the magnitude of this
observed discrepancy. A more probable explanation is
that the error and limitations associated with self-report
measures of physical activity [71] are also associated with
self-report measures of sedentary behaviors. Preliminary
evidence that compares activity levels as measured by a
pedometer and the IPAQ would suggest that direct com-
parisons are unwise as evident by low correlations
between the two methods [72].
Outcome measures were only assessed at baseline and
week 12. Participants were asked to record their pedome-
ter readings from intermittent sub-goals in self-recorded
diaries. Completion of these was not an essential require-
ment of participants and as such these were often incom-
plete. The level of missing data in these diaries made it
impractical to perform statistical analysis on a week by
week basis. We were reluctant to constantly monitor par-
ticipants to try and mirror a 'real-world' scenario. As a
result we were unable to determine whether participants
actually achieved, or exceeded, their targets in the periods
between assessments. Therefore, the possibility remains
that, in a worst case scenario, participants increased their
physical activity levels only during week 12 in order to
achieve their final target; although such a substantial
increase in step-counts over a one week period would be
unlikely. A previous study from our research group [58]
that followed individuals throughout the intervention
reported an incremental increase in step-counts on a week
by week basis. While only measuring at pre and post inter-
vention may be seen as a limitation of the current study,
this approach removes the possibility of increased motiva-
tion through researcher presence and may also decrease
the risk of participant drop-out due to repeated meetings.
Making completion of step-count diaries a requirement of
participants would have increased the level of data availa-
ble for analysis. However, this substantially increases the
responsibility on the participant which, over a prolonged
time-period, may provide a potential source for partici-
pant drop-out. Conversely, filling in the step-count diaries
on a regular basis may act as an extrinsic motivational fac-
tor; which could potentially mask the effects of the walk-
ing program or the consultation. The recent systematic
review on pedometer use suggests that future trials com-
pare pedometer use with versus without a step-count diary
[29] and the results of this study support this suggestion
given the issues discussed above.
In this study contact with intervention group participants
was minimal and yet significant behavior change was still
achieved. Following the RE-AIM framework for health
behavior interventions [73], this intervention was simple
to implement, was efficacious at an individual level and
has the capacity to be adopted and implemented within a
variety of real-world settings.
Whilst the current study was successful in increasing the
daily walking of participants, there was no effect on any of
the health-related outcomes measured other than a small
to medium, significant increase in positive affect reported
by the intervention group. There is contradicting evidence
regarding the relationship between walking and affect.
Some researchers have suggested that walking may not be
performed at a sufficient intensity to produce correspond-
ing positive changes in affect [74]. Conversely, the current
study supports research that has demonstrated a positive
benefit on affect following a walking intervention
[14,18,75]. Researchers have also demonstrated that
short, acute bouts of walking may also improve affect
[17,76]. These findings provide support for walking as a
pleasurable activity and it has been proposed that this
enjoyment is linked to intrinsic motivation and subse-
quent adherence to physical activity [76].
The lack of changes in the other health-related outcomes
measured in this study may not be unexpected given the
pragmatic approach of the walking intervention. The
walking program was designed to increase participants'
walking in graduated bi-monthly stages: participants
began the program by accumulating an additional 1,500
steps on at least three days of the week for the first two
weeks before progressing with the frequency of this goal
and then the quantity of walking. This approach was uti-
lized to allow participants the opportunity to follow pro-
gressive short term goals in order to reinforce successful
strategies or attempt alternative strategies in order to
achieve their goals. Subsequently, if this approach was fol-
lowed by participants, the goal of accumulating an addi-
tional 3,000 steps at least five days of the week was only
applicable for the final six weeks of the intervention.Page 11 of 15
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in body weight, BMI, percentage body fat, blood pressure
and the cholesterol:HDL ratio after a walking interven-
tion, report means and ranges of duration and frequency
consistent with the 30 minutes (3000 steps), five days a
week target promoted in the current study. These meta-
analyses used data from studies ranging between eight
and 104 weeks in length.
It may be the case therefore, that a period longer than six
weeks at this duration and frequency is required to allow
positive physiological changes to occur. Future follow-up
stages of the WWW study will attempt to evaluate this
aspect. However, as previously mentioned; we are unable
to conclude whether participants strictly followed the
graduated approach or whether they were successful in
doing so throughout the program. Indeed, previous work
investigating the dose-response relationship has shown
that it can take up to two years for an increase in HDL to
occur as the result of exercise training [77]. On the other
hand similar changes in HDL and other anthropometric
variables have occurred after 12 weeks in other investiga-
tions [16,78]. It is possible, therefore, that the current
intervention may have resulted in positive health benefits
if it had continued.
Although we may not have expected physiological
changes at week 12 due to the graduated walking pro-
gram, we must consider alternative methodological con-
siderations of the study that may have contributed to the
lack of significant changes in health outcomes. With the
exception of BMI, participants' health outcomes values
were deemed to be within normal ranges at baseline. Sig-
nificant, and clinically meaningful, changes will conse-
quently be harder to achieve in this population and may
indeed be unnecessary for many participants. It has been
recommended that 45–60 minutes of moderate physical
activity per day is required for weight maintenance [79].
Therefore it was unlikely that these changes would have
occurred following an increase of approximately 30 min-
utes of walking. This study also did not attempt to control
for dietary factors. Previous studies have demonstrated
that calorific restriction is a more effective weight loss tool
than physical activity [80]. As we did not control for or
monitor diet it is possible that participants may have com-
pensated for the increase in physical activity by increasing
energy intake or by deceasing energy expenditure during
other parts of the day. Such a possibility is supported by
previous research showing that there is an increase in
appetite after a single bout of exercise [81] although this
is not always been the case [82]. In the current study no
measure of energy intake/expenditure was made hence we
are unable to determine whether an increase in energy
intake, or decreasing energy expenditure in other parts of
the day, has counteracted the increase in energy expendi-
ture due to the walking.
Finally, it may be that the intensity of the walking under-
taken by the participants was not sufficient to stimulate
health benefits. It is possible that the changes in step-
count observed in our participants were caused by short
(less than 10 minutes) bouts at low speeds. To date there
has been little community based work where the intensity
of physical activity has been closely monitored. Results
from this and similar community based studies
[14,16,23] present equivocal and conflicting findings of
producing corresponding physiological changes follow-
ing successful behavior change. This illustrates that in
comparison with controlled, laboratory based studies
positive changes in health may be more difficult to
achieve in a real world setting, where the frequency, dura-
tion and intensity of the intervention cannot be objec-
tively measured.
Study strengths and limitations
Strengths of this study include using a sealed pedometer
at baseline and the use of a pedometer with a 7-day mem-
ory which negates the need for participants to record their
daily steps. This study is also one of the first UK based,
adequately powered randomized controlled trials to
examine the effectiveness of pedometers as motivational
tools within a community based, non-clinical sample. The
use of a multidisciplinary approach to provide measures
of health related outcomes adds significantly to the study,
and it is of considerable importance that all analyses were
performed on an intention to treat basis. The lack of an
intention to treat approach in the literature has been iden-
tified as a weakness when considering application to a
population setting [15].
Although the pedometer is a useful measurement tool
with regards to ambulatory physical activity, one limita-
tion of the instrument is that the lack of any direct meas-
ure of intensity makes it difficult to draw conclusions
about time spent in moderate or vigorous physical activ-
ity. Pedometers are currently being developed that address
the issue of measuring only walking at a pre-determined
moderate intensity (aerobic steps) although further
research into the validity of these measures is required
before they can be used confidently in intervention stud-
ies. The pedometer measures ambulatory activity, not
strictly walking, which suggests that the increase in steps/
day found between baseline and week 12 in the interven-
tion group could be attributed to other forms of physical
activity. However, participants were asked to remove the
pedometer whilst engaging in structured sport or exercise,
and self-report measures of physical activity do not show
evidence of changes in ambulatory activity other than
walking.Page 12 of 15
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In summary, this study has demonstrated that a 12-week
pedometer-based walking program in combination with a
physical activity consultation was an effective way to
increase walking, reduce sedentary behavior and increase
positive affect in a community based sample not meeting
current physical activity recommendations. The interven-
tion was relatively simple to implement and has the
capacity to be reproduced in a variety of settings. The
intervention was not sufficient to induce beneficial physi-
ological changes. Future stages of this study will examine
adherence to the intervention, compare the effects of the
walking program with versus without the physical activity
consultation and provide longitudinal data on health
related outcomes.
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